Clinical Trials Directory

Trials / Sponsors / MedPacto, Inc.

MedPacto, Inc.

Industry · 10 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingStudy to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Pro
Osteosarcoma
Phase 1 / Phase 22023-05-01
WithdrawnVactosertib and Imatinib Combination in Patients with Advanced Desmoid Tumor/aggressive Fibromatosis (DT/AF)
Dermoid
Phase 22021-06-01
TerminatedVactosertib in Combination with Pembrolizumab for PD-L1 Positive Non-small Cell Lung Cancer (NSCLC) Subjects
Carcinoma, Non-Small-Cell Lung
Phase 22020-12-17
WithdrawnVactosertib with Durvalumab in Urothelial Carcinoma Failing Checkpoint Inhibition
Urothelial Carcinoma Recurrent, Advanced Urothelial Carcinoma
Phase 22019-12-13
CompletedPhase 1b/2a, Open-label Study of Vactosertib in Combination With Durvalumab in Advanced NSCLC
Non-Small Cell Lung Cancer Metastatic
Phase 1 / Phase 22019-02-11
CompletedVactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric Cancer
Metastatic Colorectal Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Phase 1 / Phase 22018-12-20
CompletedTEW-7197 with Paclitaxel for the Treatment of Metastatic Gastric Cancer
Metastatic Gastric Cancer
Phase 1 / Phase 22018-08-15
CompletedEffect of Food on the Pharmacokinetics of TEW-7197 in Healthy Subjects
Healthy Volunteers
Phase 12018-08-08
CompletedDose Escalation and Proof-of-Concept Studies of Vactosertib (TEW-7197) Monotherapy in Patients With MDS
Myelodysplastic Syndromes
Phase 12018-01-04
CompletedFirst in Human Dose Escalation Study of Vactosertib (TEW-7197) in Subjects With Advanced Stage Solid Tumors
Advanced Stage Solid Tumors
Phase 12014-07-29